Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Critical Limb Ischemia (CLI): later-stage trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Critical Limb Ischemia (CLI): 3 US clinical trials tracked, none currently recruiting.
Critical Limb Ischemia (CLI) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 2 of these trials.
Enrollment posture brief
Registry condition critical-limb-ischemia-cli
OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Critical Limb Ischemia (CLI) has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Critical Limb Ischemia (CLI) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Critical Limb Ischemia (CLI) is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
LIFE-BTK Randomized Controlled Trial
Abbott Medical Devices
NCT04227899
LIFE-BTK PK Sub-study
Abbott Medical Devices
NCT05208905
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Pluristem
NCT03006770
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Critical Limb Ischemia (CLI) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Critical Limb Ischemia (CLI) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Critical Limb Ischemia (CLI) page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Critical Limb Ischemia (CLI) trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Abbott Medical Devices sponsors the most Critical Limb Ischemia (CLI) trials on record, review their full trial history before evaluating a specific study. See Abbott Medical Devices's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Critical Limb Ischemia (CLI) condition card totals 3 registered trials; most-linked intervention Esprit BTK Device; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.